Literature DB >> 2755556

Choline levels are increased in cerebrospinal fluid of Alzheimer patients.

R Elble1, E Giacobini, C Higgins.   

Abstract

We measured choline (Ch), acetylcholinesterase activity (AChE) and total protein in the cerebrospinal fluid (CSF) of 66 Alzheimer patients (ages 54-89 years) and 22 age-matched controls (ages 52-80 years), looking for markers of the well-established cholinergic deficit and neuronal degeneration in Alzheimer disease (AD). Three or more lumbar punctures were performed in 21 patients over a span of 24 months in order to study the changes in these CSF components with disease progression. We found a statistically significant reduction in AChE and an increase in Ch with advancing dementia. These changes were not related to patient age. We suggest that the rise in CSF choline is related to neuronal membrane breakdown and reduced Ch uptake by cholinergic neurons. The reduction in CSF AChE is consistent with the depletion of cholinergic neurons in AD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755556     DOI: 10.1016/s0197-4580(89)80009-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease.

Authors:  G Ehrenstein; Z Galdzicki; G D Lange
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

2.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

3.  Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.

Authors:  B V Manyam; E Giacobini; J A Colliver
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

4.  Neurochemical and Neuroanatomical Plasticity Following Memory Training and Yoga Interventions in Older Adults with Mild Cognitive Impairment.

Authors:  Hongyu Yang; Amber M Leaver; Prabha Siddarth; Pattharee Paholpak; Linda Ercoli; Natalie M St Cyr; Harris A Eyre; Katherine L Narr; Dharma S Khalsa; Helen Lavretsky
Journal:  Front Aging Neurosci       Date:  2016-11-21       Impact factor: 5.750

Review 5.  Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Authors:  Roni Manyevitch; Matthew Protas; Sean Scarpiello; Marisa Deliso; Brittany Bass; Anthony Nanajian; Matthew Chang; Stefani M Thompson; Neil Khoury; Rachel Gonnella; Margit Trotz; D Blaine Moore; Emily Harms; George Perry; Lucy Clunes; Angelica Ortiz; Jan O Friedrich; Ian V J Murray
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

6.  Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.

Authors:  Nick van Wijk; Rosalinde E R Slot; Flora H Duits; Marieke Strik; Egbert Biesheuvel; John W C Sijben; Marinus A Blankenstein; Jörgen Bierau; Wiesje M van der Flier; Philip Scheltens; Charlotte E Teunissen
Journal:  Alzheimers Dement (Amst)       Date:  2017-05-16

7.  Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.

Authors:  Andrew McGarry; John Gaughan; Cory Hackmyer; Jacqueline Lovett; Mohammed Khadeer; Hamza Shaikh; Basant Pradhan; Thomas N Ferraro; Irving W Wainer; Ruin Moaddel
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.